Weight Management Clinical Blueprint®
Covering GLP-1 for Weight Management — Driving Measurable Clinical Results
A mid-sized self-funded employer partnered with Northwind Health to offer GLP-1 medications as a covered benefit — with the clinical guardrails and coaching infrastructure to make every dollar count.
Program Results
The Numbers Tell the Story
An average weight loss of 31.8 pounds per member — representing an estimated 12–16% reduction in body weight for a population entering the program with an average BMI of 37.3 — drives meaningful improvement in blood pressure by reducing vascular resistance and decreasing overall cardiac workload. This degree of sustained weight reduction is well above the commonly recognized prevention threshold and is strongly associated with materially lowering progression to Type 2 diabetes in high-risk populations, while simultaneously reducing long-term cardiovascular risk.
Average pounds lost per engaged member
Total pounds lost across the enrolled population
Total active program enrollees
Members achieving at least 5% weight loss
Members with documented controlled blood pressure
Members adherent to medication therapy
Annualized savings from clinically-reviewed GLP-1 PA denials
Health coaching & pharmacist engagement rate
Clinical Controls for Rising GLP-1 Spend
| Utilization Rate | # of Participants | Total Cost | |
|---|---|---|---|
| With Northwind Guardrails | 1% | 40 | $360K |
| National Average | 6% | 240 | $2.9M |
The Challenge
Fluctuating Eligibility.
Rising Specialty Spend.
No Margin for Error.
For an employer who made the decision to cover GLP1 with their PBM, costs were escalating with no end in sight. They asked the question – are people losing weight and getting healthier? Their heart to help their members with this expensive treatment still needed fiduciary balance.
GLP-1 medications had arrived as a genuine clinical breakthrough for weight management and diabetes. But for self-funded employers, they arrived with a problem: extraordinary cost exposure and no built-in accountability.
Key Concerns
- Rising GLP-1 costs with unclear clinical outcomes.
- Lack of strategy to manage GLP1 spend given 42% of the US population could quality for a GLP1 for weight loss.
- Significant crossover between obesity and Type 2 diabetes in the eligible population.
- A fragmented medication management system that left members — and the plan — exposed.
"But for self-funded employers, they arrived with a problem: extraordinary cost exposure and no built-in accountability."
The Approach
Covered. Coordinated. Clinically Supervised.
Northwind Health designed a carve-out Weight Management Program that gave members access to GLP-1 therapy while embedding the clinical structure needed to produce real outcomes — and contain unnecessary spend.
The program operated at the intersection of three disciplines most health plans treat as separate: Pharmacy Benefit Management, Chronic Disease Management, and clinical reauthorization oversight. Bringing all three to bear on a single population isn’t just efficient — it’s transformative.
The program was built around two goals:
- Produce measurable health outcomes that improve the bottom line.
- Eliminate the waste, fraud, and abuse that inflate costs without improving care.
How It Works
- Every enrolled member receives dedicated health coach and pharmacist support.
- Prior authorizations for GLP-1s are completed with clinical review — not rubber-stamped.
- Members who do not meet ongoing clinical criteria face structured de-escalation.
- Reauthorization checkpoints at 12 months ensure continued clinical appropriateness.
- Members with diabetes crossover receive integrated chronic disease management alongside weight management support.
GLP-1 STEWARDSHIP
Responsible Access Is Not Restricted Access
Northwind’s approach to GLP-1 coverage is designed to protect high-risk members who need these medications — and protect the plan from coverage that doesn’t meet clinical criteria.
Prior authorizations completed for high-cost GLP-1 medications.
Active members on GLP-1 therapy.
Members who have achieved a BMI below 25 (healthy weight).
Denied PA rate — removed abuse from the health plan.
Member Stories
These Aren’t Hypotheticals.
These are members in the program — and what happened when they had real support.
From Metabolic Risk to Renewed Vitality
This member enrolled in December 2024 carrying hypertension, hyperlipidemia, Type 2 diabetes, and metabolic syndrome — following recent hernia surgery and a heart ablation for SVT. Her clinical starting point was high-risk by any measure.
Within the program year:
- Weight dropped from 180 lbs to 155 lbs
- BMI moved from obese to healthy range
- Waist circumference reduced by 8 inches (43” → 35”)
- A1C improved from 5.7% to 5.1%
- Blood pressure normalized: 136/84 → 112/80
“I feel amazing — this is such a gift. I feel lighter, stronger, and able to do things I couldn’t before. I’ve gone from a size 18 to a size 10, and I feel like the best version of myself.”
From High Risk to Hope: A1c 15% → 7.5%
A member entered the program in February with an A1c of 15% — one of the highest-risk cases in the cohort. By May, that number had dropped to 11%. By August, the member was at 7.5% and closing in on controlled range.
What made the difference wasn’t just medication. It was continuity. Northwind’s team supported the member through an unplanned hospital stay, coordinated their continuous glucose monitor, and maintained pharmacist and health coach engagement throughout.
“This drug has changed my life. Not only has it reduced my A1C to normal, as a type 2 diabetic, but it’s the first time I have been able to lose weight and be healthier. Northwind has been instrumental in all my progress with all the support and supplies I need.”
One Seat. For the First Time in Years.
During two vacations, a member traveled by plane and — for the first time in several years — didn’t need to request a seatbelt extender. On previous trips, he’d had to purchase two seats. He also purchased a new car and, for the first time in years, could comfortably fit in a smaller vehicle. Six months into the program, the physical transformation was visible in ways that mattered to him personally.
“I started this program skeptical and focused on small changes — tracking food, learning what to eat, and trusting the process. I can’t believe how far I’ve come! I feel lighter, stronger, and in control again. I’ve lost over 40 pounds and several inches, and even my clothes can’t keep up with my progress!”
A Kidney Patient’s Best Labs Yet
A member with a chronic kidney condition recently reported his best labs ever for filtration rate, according to his nephrologist. Having lost 12 pounds — 5% of his starting weight — his new lifestyle habits may meaningfully delay a future kidney transplant. For this member, the program didn’t just improve a number. It bought time.
Married 24 Years. Wearing His Ring Again.
This member had struggled with obesity for decades. After working with his Northwind health coach and pharmacist, he is now able to wear his wedding ring comfortably for the first time in 20 years. His improved health also allowed him to discontinue medication for overactive bladder — a secondary benefit he hadn’t anticipated when he enrolled.
THE BOTTOM LINE
Coverage Without Accountability Is Just Cost.
GLP-1 medications represent one of the most consequential — and expensive — coverage decisions self-funded employers face today. The question is no longer whether to cover them. It’s how.
Northwind’s Weight Management Clinical Blueprint® gives employers a clinically rigorous answer. Members get access to medications that work, paired with the health coaching and pharmacist oversight that makes them work better. Plans get the financial guardrails that protect against unnecessary spend — and the outcomes data to justify every dollar invested.
Responsible coverage isn’t restricted coverage. It’s smarter coverage.
